Cargando…

PT673. Pharmacological analysis of nicotine-induced tremor

Detalles Bibliográficos
Autores principales:	Kunisawa, Naofumi, Atsuta, Yudai, Iha, Higor, Nohara, Takanori, Ohno, Yukihiro, Shimizu, Saki, Tokudome, Kentaro, Yoshikawa, Kento
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617005/ http://dx.doi.org/10.1093/ijnp/pyw044.673

Ejemplares similares

PT667. Nicotine evokes convulsive seizures by activating amygdala neurons partly through α7nACh receptors
por: Iha, Higor A., et al.
Publicado: (2016)

Mechanisms Underlying Dopaminergic Regulation of Nicotine-Induced Kinetic Tremor
por: Kato, Masaki, et al.
Publicado: (2022)

Nicotine Elicits Convulsive Seizures by Activating Amygdalar Neurons
por: Iha, Higor A., et al.
Publicado: (2017)

PT678. Enhancement of the accumbal dopamine release by the gene mutation of synaptic vesicle protein 2A (Sv2a(L174Q))
por: Tokudome, Kentaro, et al.
Publicado: (2016)

Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects
por: Ohno, Yukihiro, et al.
Publicado: (2019)

Emerging Roles of Astrocyte Kir4.1 Channels in the Pathogenesis and Treatment of Brain Diseases
por: Ohno, Yukihiro, et al.
Publicado: (2021)

A Missense Mutation of the Gene Encoding Synaptic Vesicle Glycoprotein 2A (SV2A) Confers Seizure Susceptibility by Disrupting Amygdalar Synaptic GABA Release
por: Tokudome, Kentaro, et al.
Publicado: (2016)

Involvement of aspartoacylase in tremor expression in rats
por: Nishitani, Ai, et al.
Publicado: (2016)

Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission
por: Tokudome, Kentaro, et al.
Publicado: (2016)

Glycine-Binding Site Stimulants of NMDA Receptors Alleviate Extrapyramidal Motor Disorders by Activating the Nigrostriatal Dopaminergic Pathway
por: Shimizu, Saki, et al.
Publicado: (2017)

Involvement of NMDA receptors in tremor expression in Aspa/Hcn1 double-knockout rats
por: Nishitani, Ai, et al.
Publicado: (2020)

Hcn1 Is a Tremorgenic Genetic Component in a Rat Model of Essential Tremor
por: Ohno, Yukihiro, et al.
Publicado: (2015)

Imbalance of glutamatergic and GABAergic neurotransmission in audiogenic seizure-susceptible Leucine-rich glioma-inactivated 1 (Lgi1)-mutant rats
por: Kinboshi, Masato, et al.
Publicado: (2023)

PT675. Modulation by cerebellar D3 receptors of dyskinesia induction in rats
por: Mukai, Takahiro, et al.
Publicado: (2016)

THU673 Unusual Metastasis Of Differentiated Thyroid Carcinoma
por: Aiad, Mina, et al.
Publicado: (2023)

FRI673 REMS Technology For The Evaluation Of BMD In Hypothyroidism
por: Lombardi, Fiorella Anna, et al.
Publicado: (2023)

Inwardly Rectifying Potassium Channel Kir4.1 as a Novel Modulator of BDNF Expression in Astrocytes
por: Ohno, Yukihiro, et al.
Publicado: (2018)

XPF-673C>T Polymorphism Effect on the Susceptibility to Esophageal Cancer in Chinese Population
por: Liu, Yingwen, et al.
Publicado: (2014)

SAT673 Novel Mutation Of TBX3 Associated With Morbid Obesity In Human
por: Alkaissi, Hussam R, et al.
Publicado: (2023)

Inhibition of Inwardly Rectifying Potassium (Kir) 4.1 Channels Facilitates Brain-Derived Neurotrophic Factor (BDNF) Expression in Astrocytes
por: Kinboshi, Masato, et al.
Publicado: (2017)

Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer
por: Wilkerson, Paul M, et al.
Publicado: (2016)

Prognostic Nomogram for Childhood Acute Lymphoblastic Leukemia: A Comprehensive Analysis of 673 Patients
por: Mao, Rui, et al.
Publicado: (2020)

SAT-673 Acute Onset Type 1 Diabetes Mellitus Caused by the Checkpoint Inhibitor Nivolumab
por: Ansari, Mohammad Jamal Uddin, et al.
Publicado: (2020)

BMN673 Is a PARP Inhibitor with Unique Radiosensitizing Properties: Mechanisms and Potential in Radiation Therapy
por: Soni, Aashish, et al.
Publicado: (2022)

P673: ASCIMINIB MANAGMENT IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH T315I MUTATION.
por: Kuzmina, Elena, et al.
Publicado: (2023)

The Phase Relations of the Co-Ni-In Ternary System at 673 K and 873 K and Magnetic Properties of Their Compounds
por: Yang, Tonghan, et al.
Publicado: (2020)

Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD in vitro
por: Guyon, Antoine, et al.
Publicado: (2021)

Insertion of the protective APP A673T mutation by CRISPR/Cas9 base editing or PRIME editing.
por: Tremblay, Jacques, et al.
Publicado: (2021)

Tremor in a Bassoonist: Tremor in Dystonia or Essential Tremor?
por: Park, Jung E, et al.
Publicado: (2016)

Vim thalamotomy in a patient with Holmes’ tremor and palatal tremor - Pathophysiological considerations
por: Maki, Futaba, et al.
Publicado: (2015)

MON-673 Use of Metabolic Syndrome Severity to Assess Treatment with Vitamin-E and Pioglitazone for Non-Alcoholic Steatohepatitis
por: DeBoer, Mark Daniel, et al.
Publicado: (2020)

Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity
por: Limegrover, Colleen S., et al.
Publicado: (2020)

673. Sniffing Out Adherence: Evaluation of a Clostridioides difficile guideline at a Tertiary Academic Medical Center
por: Mei, Tiffany, et al.
Publicado: (2023)

PT565. Prenatal nicotine exposure impairs adolescent mouse hippocampal function
por: TANASE, Shota, et al.
Publicado: (2016)

G(673) could be a novel mutational hot spot for intragenic suppressors of pheS5 lesion in Escherichia coli
por: Ponmani, Thangaraj, et al.
Publicado: (2014)

Whole-Genome Sequence of Ralstonia solanacearum P673, a Strain Capable of Infecting Tomato Plants at Low Temperatures
por: Bocsanczy, Ana M., et al.
Publicado: (2014)

PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia
por: Herriott, Ashleigh, et al.
Publicado: (2015)

PS121. Evaluation of extrapyramidal side effects in the treatment of behavioral and psychological symptoms of dementia (BPSD): Interactions between anti-Alzheimer drugs and antidepressants
por: Shimizu, Saki, et al.
Publicado: (2016)

Pharmacological Treatment of Tremor in Parkinson’s Disease Revisited
por: Pirker, Walter, et al.
Publicado: (2023)

Pharmacological and Physiological Characterization of the Tremulous Jaw Movement Model of Parkinsonian Tremor: Potential Insights into the Pathophysiology of Tremor
por: Collins-Praino, Lyndsey E., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_h10l04ghtuh1vr0sgipeq9k9ck